Failure of preconditioning to improve postcardioplegia stunning of minimally infarcted hearts

Annals of Thoracic Surgery

Volumn 64, Issue 6, 1997, Pages 1735-1741

  Faris, Bouchaib ^a   Peynet, Jacqueline ^a   Wassef, Michel ^a   Bel, Alain ^a   Mouas, Christian ^a   Duriez, Micheline ^a   Menasché, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DRAFLAZINE; INOSINE;

ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; HEART ARREST; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STUNNED HEART MUSCLE;

ADENOSINE; ANIMALS; CORONARY CIRCULATION; CREATINE KINASE; HEART ARREST, INDUCED; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; RABBITS; VENTRICULAR FUNCTION, LEFT;

EID: 0031415549     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00861-8     Document Type: Article

References (26)

1. Bolling SF, Olszanski DA, Childs KF, Gallagher KP, Ning XH. Stunning, preconditioning, and functional recovery after global myocardial ischemia. Ann Thorac Surg. 58:1994;822-827.
2. Illes RW, Wright JK, Inners-McBride K, Yang CJ, Tristan A. Ischemic preconditioning improves preservation with crystalloid cardioplegia. Ann Thorac Surg. 58:1994;1481-1485.
3. Ovize M, Przyklenk K, Kloner RA. Preconditioning. Circulation. 85:1992;2247-2254.
4. 1 receptor activation. Basic Res Cardiol. 88:1993;576-593.
5. 1 analogue and ischemic preconditioning in isolated rabbit hearts. Ann Thorac Surg. 60:1995;1698-1703.
6. Kolocassides KG, Galinanes M, Hearse DJ. Dichotomy of ischemic preconditioning. Improved postischemic contractile function despite intensification of ischemic contracture. Circulation. 93:1996;1725-1733.
7. Asimakis GK, Lick SD, Conti VR. Transient ischemia cannot precondition the rabbit heart against postischemic contractile dysfunction. Ann Thorac Surg. 62:1996;543-549.
8. Alkhulaifi AM, Yellon DM, Pugsley W. Preconditioning the human heart during aorto-coronary bypass. Eur J Cardiothorac Surg. 8:1994;270-276.
9. Perrault LP, Menasché P, Bel A, et al. Ischemic preconditioning in cardiac surgery a word of caution . J Thorac Cardiovasc Surg. 112:1996;1378-1386.
10. Jennings RB. Overview of preconditioning against lethal cell injury. Marber MS, Yellon DM. Ischaemia. Preconditioning and adaptation. 1st ed. 1996;1-20 Bios Scientific Publishers, Oxford.
11. Cave AC, Hearse DJ. Ischaemic preconditioning and contractile function studies with normothermic and hypothermic global ischaemia . J Mol Cell Cardiol. 24:1992;1113-1123.
12. Galinanes M, Argano V, Hearse DJ. Can ischemic preconditioning ensure optimal myocardial protection when delivery of cardioplegia is impaired? Circulation. 92:(Suppl 2):1995;389-394.
13. 1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356.
14. Headrick J. Ischemic preconditioning bioenergetic and metabolic changes and the role of endogenous adenosine . J Mol Cell Cardiol. 28:1996;1227-1240.
15. Parratt JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 1994;15(1):19-25 (published erratum appears in Trends Pharmacol Sci 1994;15(2):39.
16. Parratt JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 1994;15(1):19-25 (published erratum appears in Trends Pharmacol Sci 1994;15(2):39.
17. Van Belle H. Nucleoside transport inhibition a therapeutic approach to cardioprotection via adenosine? Cardiovasc Res. 27:1993;68-76.
18. Van Belle H, Goossens F, Wynants J. Biochemical and functional effects of nucleoside transport inhibition in the isolated cat heart. J Mol Cell Cardiol. 21:1989;797-805.
19. Downey JM, Cohen MV. Mechanisms of preconditioning correlates and epiphenomena . Marber MS, Yellon DM. Ischaemia. Preconditioning and adaptation. 1st ed. 1996;21-34 Bios Scientific Publishers, Oxford.
20. Lasley RD, Konyn PJ, Hegge JO, Mentzer RM. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol. 269:1995;1460-1466.
21. Yao Z, Gross GJ. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Circulation. 89:1994;1229-1236.
22. Abd-Elfattah AS, Ding M, Wechsler AS. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning) is it preconditioning? . J Thorac Cardiovasc Surg. 110:1005;328-339.
23. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 70:1992;223-233.
24. Hide EJ, Thiemermann C. Limitation of myocardial infarct size in the rabbit by ischemic preconditioning is abolished by sodium 5-hydroxydecanoate. Cardiovasc Res. 31:1996;941-946.
25. Menasché P, Kevelaitis E, Mouas C, Grousset C, Piwnica A, Bloch G. Preconditioning with potassium channel openers a new concept for enhancing myocardial protection? J Thorac Cardiovasc Surg. 110:1995;1606-1614.
26. Menasché P, Mouas C, Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia? Ann Thorac Surg. 61:1996;1764-1768.